Cyclopentanecarboxylicacid, 2-[(1R)-2-(b-D-glucopyranosyloxy)-1-methylethyl]-5-methyl-,(1S,2R,5S)- (9CI) (110344-61-1)

Identification
Name:	Cyclopentanecarboxylicacid, 2-[(1R)-2-(b-D-glucopyranosyloxy)-1-methylethyl]-5-methyl-,(1S,2R,5S)- (9CI)
Synonyms:	Cyclopentanecarboxylicacid, 2-[2-(b-D-glucopyranosyloxy)-1-methylethyl]-5-methyl-,[1S-[1a,2b(S*),5a]]-; Nepetariaside
CAS:	110344-61-1
Molecular Formula:	C16H28 O8
Molecular Structure:
Properties
Safety Data

Other Product

Cyclohexanone, 2-[1-[(b-D-glucopyranosyloxy)methyl]ethenyl]-5-methyl-,(2R,5S)- (9CI)
2H-Pyran-5-carboxylicacid, 3-ethenyl-2-(b-D-glucopyranosyloxy)-3,4-dihydro-4-(2-oxoethyl)-,[(1S,2R,3S,5S)-3-[[[(1S,2R,3S)-3-ethenyl-2-(b-D-glucopyranosyloxy)-3,4-dihydro-4-(2-oxoethyl)-2H-pyran-5-yl]carbonyl]oxy]-5-[(1R)-1-(hydroxymethyl)-2-methoxy-2-oxoethyl]-2-methylcyclopentyl]methylester, (1S,2R,3S)- (9CI)
Cyclohexanethiol,5-methyl-2-(1-methylethyl)-,(1S,2R,5S)-(9CI)
Cyclohexanethiol,5-methyl-2-(1-methylethyl)-,(1R,2R,5S)-(9CI)
Hexadecanamide,N-[(1S,2S,3R)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxyheneicosyl]-2-hydroxy-, (2R)-(9CI)
Tetracosanamide,N-[(1S,2S,3R)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxypentadecyl]-2-hydroxy-, (2R)-(9CI)
b-D-Glucopyranoside,(2E)-5-[(1S,4aR,5S,8aR)-5-[(b-D-glucopyranosyloxy)methyl]decahydro-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-pentenyl(9CI)
Cyclopentanecarboxylicacid, 1-methyl-2-(1-methylethyl)-, (1R,2R)-rel-
1,2-Cyclopentanedicarboxylic acid,bis[(1S,2R,5S)-5-methyl-2-(1-methylethyl)cyclohexyl] ester, (1R,2R)-
1,2-Cyclopentanedicarboxylic acid,mono[(1S,2R,5S)-5-methyl-2-(1-methylethyl)cyclohexyl] ester, (1R,2R)-
Docosanamide,N-[(1S,2R,3E,9E)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-3,9-heptadecadienyl]-2-hydroxy-,(2R)- (9CI)
Tetracosanamide,N-[(1S,2R,3E,9E)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-3,9-heptadecadienyl]-2-hydroxy-,(2R)- (9CI)
Cyclohexanone, 2-[2-(b-D-glucopyranosyloxy)-1-methylethylidene]-5-methyl-,(2E,5S)- (9CI)
Cyclopentanecarboxylicacid, 1-amino-2-methyl-, (1S,2R)-
D-myo-Inositol,1,2:5,6-di-O-cyclohexylidene-,3-[(1S,2R,5S)-5-methyl-2-(1-methylethyl)cyclohexyl carbonate] (9CI)
Octadecanamide,N-[(1S,2R)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-2-hydroxy-,(2R)-
Cyclopentanecarboxylicacid, 1-amino-2-methyl-, (1R,2R)-
2-Butenoic acid,3-methyl-, 4-(cyanomethylene)-5-(b-D-glucopyranosyloxy)-2,3-dihydroxycyclohexyl ester, (1S,2R,3S,4Z,5R)-(9CI)
Hexadecanamide,N-[(1S,2S,3R,12Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Hexadecanamide,N-[(1S,2S,3R,8Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-8-heneicosenyl]-2-hydroxy-,(2R)- (9CI)